Transcutaneous Pacing: Indications, Pad Placement, Settings and Confirming Capture
Quick Answer
Transcutaneous pacing (TCP) sends electrical impulses through two chest pads to pace the heart from outside the body. It is used for unstable bradycardia that does not respond to atropine, as a temporary stabilizing measure while you treat the cause and arrange further pacing if needed. The 2025 AHA guidelines give it a Class 2b recommendation in that role. Recent prehospital studies found false electrical capture to be common, where pacer artifact looks like a captured beat. Confirm a wide QRS with a T wave after every spike, then confirm a perfusing pulse that matches the set rate.
What Is Transcutaneous Pacing?
Transcutaneous pacing is temporary, noninvasive cardiac pacing delivered through skin pads. The StatPearls chapter on transcutaneous pacing (updated February 2026) describes it as delivering “electrical impulses through cutaneous electrode pads to achieve myocardial depolarization and temporary cardiac pacing.”
You will see it called a transcutaneous pacemaker, a transcutaneous pacer, external pacing or external cardiac pacing. They all describe the same therapy. It runs on a manual defibrillator, which StatPearls notes is common on crash carts and EMS vehicles and provides both defibrillation and pacing.
TCP is fast to start and needs no vascular access. The trade-offs are pain in a conscious patient and unreliable capture, which is why it is a temporary measure and not a definitive treatment.
When to Use Transcutaneous Pacing
Use TCP for bradycardia with hemodynamic compromise that persists after atropine, to stabilize the patient while you treat the cause and arrange further pacing if it is needed. The 2025 AHA adult advanced life support guidelines state that “if bradycardia is unresponsive to atropine, IV adrenergic agonists with rate-accelerating effects (eg, epinephrine, dopamine) or transcutaneous pacing may be effective while the adult patient is prepared for emergent transvenous temporary pacing if required” (Class 2b, LOE C-LD).
The same guideline adds a second, narrower use. Immediate pacing might be considered in unstable patients with high-degree AV block when IV or IO access is not available (Class 2b, LOE C-EO).
The AHA uses the 2018 ACC/AHA/HRS threshold of a heart rate below 50/min to define bradycardia. A slow rate alone is not the trigger. StatPearls limits TCP to patients with hypotension, acute mental status change, signs of shock or compromised organ perfusion, and its typical bradycardia indications include:
- Unstable sinus bradycardia that has not responded to drugs
- Mobitz type II second-degree AV block
- Third-degree AV block
Treat the Cause While You Pace
The AHA guideline asks you to look for reversible causes at the same time as you stabilize the rate. It names myocardial ischemia, hypoxemia, hypothyroidism, electrolyte abnormalities, increased vagal tone and medications or toxins among them.
The cause can decide whether pacing works at all. In a study of 13,270 prehospital pacing patients (Smida, 2025), 20.4% of those without CPR before pacing progressed to cardiac arrest. Pre-pacing SpO2 below 80% carried an adjusted odds ratio of 6.01 for that failure, a pre-pacing heart rate above 50 carried 2.87, and body weight over 100 kg carried 1.33.
Electrolyte disturbances are on both the AHA and StatPearls lists. For one of them, see our podcast episode on calcium in hyperkalemia.
Pacing or Drugs First?
The evidence does not separate the two. In the PrePACE feasibility trial (Morrison, 2008), survival to discharge or 30 days was 69% (29 of 42) with TCP and 70% (28 of 40) with dopamine in prehospital patients who had failed atropine. The authors calculated that a definitive trial would need 690 patients per group.
The 2025 AHA guideline reaches the same practical conclusion. It says the choice between pacing, epinephrine, dopamine or another vasoactive agent will likely depend on clinician experience and the resources available.
When Transcutaneous Pacing Won’t Help
Don’t pace routinely during an established cardiac arrest. The 2025 AHA guideline gives “routine use of electrical pacing is not recommended during the resuscitation of an established adult cardiac arrest” a Class 3: No Benefit recommendation (LOE B-R), and warns that pacing attempts can cost you high-quality CPR.
The best-known trial shows why. In the 1993 NEJM trial of EMT pacing in asystole (Cummins), pacing by EMTs produced no significant survival benefit in patients with asystolic cardiac arrest.
That recommendation covers arrest, not the period after it. In the 2026 multicenter EMS cohort discussed below, 33.8% of paced patients were paced after ROSC. For the wider post-arrest picture, see our post-ROSC care episode.
StatPearls lists no absolute contraindications. It does flag these situations:
- Asymptomatic or hemodynamically stable bradycardia, where pacing is generally not indicated
- Hypothermia and drug toxicity, which may prevent effective electrical capture
- Severe allergy to the pads, where hypoallergenic pads are an alternative
Equipment and Setup
Gather everything before the pads go on, including a backup. StatPearls advises having a transvenous pacer kit and medications at the bedside in case TCP does not work.
Table 1: Transcutaneous pacing equipment checklist (adapted from StatPearls, 2026)
| Item | Why it’s there |
|---|---|
| Manual defibrillator with pacing function | Delivers the pacing current |
| Pacing/defibrillation pads (adult or pediatric size) | Choose the size by the weight range on the pad packaging |
| ECG limb leads and cables | Sensing for demand mode, depending on the device |
| Hair clippers | Pad adhesion and current delivery |
| Towel or gauze | Clean, dry skin, prepared as the device instructions direct |
| Bedside ultrasound | Confirms mechanical capture |
| Analgesics and sedatives | Pacing is painful in a conscious patient |
| Transvenous pacer kit | Backup if TCP fails |
Prepare clean, dry skin according to the device manufacturer’s instructions. Do not reach for an alcohol wipe by default, because some devices specifically prohibit alcohol for pad preparation. The LIFEPAK 15 operating instructions, for example, say not to use alcohol, tincture of benzoin or antiperspirant to prep the skin for therapy electrodes.
StatPearls also recommends clipping chest hair without abrading the skin and removing metal jewelry in contact with the skin to reduce the risk of burns.
Pad sizing is device-specific too. StatPearls describes adult pads for patients of 10 kg and over, while the LIFEPAK 15 instructions list their adult pacing electrodes for patients weighing 15 kg or more. Go by the weight range printed on the pads you have.
Pad Placement: Anteroposterior or Anterolateral?
Both positions are acceptable, and the evidence on which captures at lower current is split.
- Anteroposterior (AP): one pad on the front of the chest and the other on the back.
- Anterolateral (AL): one pad on the left lateral chest and the other on the right upper chest.
For the exact sites, and for which pad goes where, use the diagram printed on the pads or in your device’s operating instructions. Manufacturers’ diagrams differ, and getting them wrong has a cost. The LIFEPAK 15 instructions note that if the electrode placement is reversed, more pacing current may be needed to achieve capture.
A 2022 crossover trial (Moayedi) found the mean pacing threshold was 33 mA lower with AP pads (93 vs 126 mA; 95% CI 20–45). Those patients were sedated after elective cardioversion in an electrophysiology lab, and 4 of the 20 enrolled did not capture in either position by 140 mA.
A 2026 trial in bradycardic patients (Goldschmied) did not reproduce the difference. In 16 patients with symptomatic bradycardia, the median threshold was 125 mA with AP pads and 140 mA with AL pads (p = 0.53), and beta-blocker use and lower myocardial mass were linked to higher thresholds. The authors note their results “do not align with prior work investigating a monitor with pulsed current delivery,” so the device may matter.
Table 2: Pad-position trials compared
| Moayedi, 2022 | Goldschmied, 2026 | |
|---|---|---|
| Patients | 20 enrolled, EP lab after elective cardioversion | 16 with symptomatic bradycardia |
| Design | Prospective crossover | Prospective crossover |
| AP threshold | Mean 93 mA | Median 125 mA |
| AL threshold | Mean 126 mA | Median 140 mA |
| Result | AP 33 mA lower (95% CI 20–45) | No significant difference (p = 0.53) |
| Other finding | 4 of 20 did not capture in either position | Beta-blockers and lower myocardial mass raised thresholds |
The 2025 AHA guideline lists optimal pad placement as a research gap, so either position is defensible for now. If one position does not capture, re-siting the pads is the usual next move (see the steps below).
How to Perform Transcutaneous Pacing, Step by Step
These steps follow the StatPearls technique. Skin preparation, pad sites, output range and the margin above threshold vary by device, so your device’s operating instructions take priority wherever they differ.
- Prepare clean, dry skin as the device instructions direct, then attach the ECG limb leads.
- Apply the pads in the AP or AL position shown on the manufacturer’s diagram, avoiding implanted devices, medication patches and broken skin.
- Press each pad down until it is fully adhered.
- Switch the defibrillator from defibrillation to pacing mode.
- Select demand (VVI) mode if your device offers it.
- Confirm the monitor is sensing intrinsic beats, and adjust the gain until it is.
- Set the rate at 60–80 bpm, above the patient’s intrinsic rate.
- Increase the current in 5–10 mA steps until every pacer spike is followed by a QRS complex.
- Confirm mechanical capture with a pulse, ultrasound, or a pulse oximetry or arterial line rate that matches the set rate.
- Set the current above the capture threshold by the margin your device’s instructions specify.
- Give analgesia, with light sedation if needed, once pacing is under way.
- Leave the monitor leads in place for as long as you pace.
In a patient who is periarrest from bradycardia, StatPearls advises going straight to the device’s maximum output for fast capture, then reducing the current as tolerated. Maximum output differs between devices, so know the limit on yours.
If you still have no capture at high output, move the pads. LITFL’s pacing summary (expert teaching source) suggests re-siting the pads if there is no capture at 120–130 mA, and both pad trials above included patients who needed more than that.
The margin above threshold is often called the safety margin, and it is not one universal number. StatPearls suggests 5–10 mA above the capture threshold, to maintain consistent capture “while allowing an appropriate margin for error.” The ZOLL X Series Operator’s Guide describes the ideal pacer current as the lowest value that maintains capture, “usually about 10% above threshold.” Use the figure for the device in front of you.
Confirming Capture: Electrical, Mechanical and False Capture
Capture has two parts, and you need both. Electrical capture means the ventricle depolarizes after each impulse. Mechanical capture means that depolarization produces a pulse.
The 2025 AHA guideline notes “persistent challenges for clinicians in achieving and maintaining both electrical and mechanical capture during pacing.” In recent prehospital studies, a pacer that looked like it was working often was not.
Electrical Capture
True electrical capture looks like a wide QRS complex followed by a T wave after every pacer spike. A large pacer artifact without that T wave is the pattern to distrust.
In a 2024 paramedic case series (Kimbrell), 19 of 23 paced patients (82.6%) had false electrical capture. Patients with true capture had a median systolic blood pressure rise of 40 mmHg, while those with false capture had a median change of minus 1 mmHg.
The current used also differed. Median current was 95 mA with true capture and 70 mA with false capture, which suggests that stopping at the first spike that resembles a QRS may leave the patient unpaced.
A larger cohort points the same way. In a 2026 multicenter EMS study (Smida) of 299 paced patients, 29 (9.7%) had sustained electrical capture. Higher delivered current (adjusted odds ratio 1.25 per 10 mA), lower body weight and a lower pre-pacing heart rate were associated with capture.
These EMS studies found frequent failure to achieve sustained capture. Both were prehospital, so the rates may differ in the ED. The practical lesson carries over: look for the T wave on the ECG, then check that the patient is actually perfusing.
Mechanical Capture
Once the monitor shows true electrical capture, check that it produces a pulse at the set rate. StatPearls lists pulse palpation, ultrasound of ventricular contraction, and a pulse oximetry or arterial line rate that matches the set rate.
Palpation can mislead. In the Kimbrell series, all 23 patients had mechanical capture documented by palpated pulse, including the 19 with false electrical capture. Pacing also causes skeletal muscle contractions (StatPearls), and the Holger group, below, described determining ventricular capture during TCP as difficult.
Ultrasound gives you a direct look. In a 15-patient ultrasound study (Holger, 2003), ultrasound and the treating physician’s clinical impression of capture showed good to excellent agreement (kappa 0.47 and 0.67).
Table 3: Ways to check capture
| Check | What it shows | Caveat |
|---|---|---|
| Monitor rhythm | Wide QRS and T wave after every spike (Kimbrell, 2024; Smida, 2026) | Pacer artifact can mimic a QRS |
| Pulse palpation | A pulse at the set rate (StatPearls) | Documented in all 23 patients in Kimbrell’s series, including 19 with false capture |
| Pulse oximetry or arterial line | Rate matches the set pacing rate (StatPearls) | Needs a reliable waveform |
| Bedside ultrasound | Ventricular contraction with each paced beat (StatPearls; Holger, 2003) | Small study (15 patients) |
The AHA guideline names pulse palpation location, pulse oximetry, continuous ETCO2 and ultrasound as capture-confirmation methods that still need study. Until that evidence arrives, use more than one.
Complications and Patient Comfort
Pain is the complication your patient will notice first. StatPearls notes that muscle contractions during pacing “can be extremely painful,” and the 2025 AHA guideline says procedural tolerance may require sedation.
Give analgesia, with light sedation where appropriate, but do not delay pacing to do it. StatPearls notes that effective analgesia does not interfere with electrical capture.
Other complications StatPearls describes:
- Skin burns, usually mild and folliculitis-like. Third-degree burns have been reported in neonates, children and older patients, and the risk rises when pads are applied incorrectly or reused.
- No skeletal or myocardial injury by CK, CK-MB or troponin after 30 minutes of pacing at 38–70 mA in the study StatPearls cites.
- Asynchronous pacing if the monitor leads come off, with discomfort and a risk of ventricular fibrillation from an R-on-T beat.
When TCP Fails: Moving to Transvenous Pacing
Not every paced patient goes on to a transvenous wire. If the cause is reversible and the rate recovers, TCP may be all the pacing the patient needs. Transvenous pacing comes in when transcutaneous pacing does not capture or the bradycardia stays unstable despite treatment. The 2025 AHA guideline rates temporary transvenous pacing as reasonable for persistent hemodynamically unstable bradycardia refractory to medical therapy (Class 2a, LOE C-LD), one class higher than TCP.
A 2024 review of transvenous pacemaker placement (Long) lists failure of transcutaneous pacing as an indication. It names the right internal jugular and left subclavian veins as the preferred sites and notes that insertion begins with a central venous catheter.
That means the transvenous procedure starts with a skill you may already have. Our step-by-step central line guide covers the access half.
Decide early whether further pacing is likely to be needed. If TCP captures, you have bought time to treat the cause and reassess. If it does not, or the patient stays unstable, you want the transvenous kit and an operator within reach.
Keeping Pacing Skills Ready
Transvenous pacing is one of the high-acuity, low-occurrence (HALO) procedures in SimKit’s Year 2 course, and transcutaneous pacing often comes before it. The hardest part of TCP is the capture judgment above, which the 2025 AHA guideline calls a persistent challenge for clinicians.
A single sim-center session is not enough on its own. As our episode on why procedural skills fade discusses, skills can decline without regular practice.
SimKit’s Year 2 course covers transvenous pacing, the procedure you may need if TCP is not enough. It runs on 30-minute monthly practice sessions that revisit each procedure three times a year.
SimKit supplies the training side: the course, the practice schedule and its training models. It does not supply clinical transvenous pacing equipment. The pacing catheter and generator come from your department, so you rehearse with the device you will use on a real patient.
Practice like this builds readiness and confidence. It does not replace credentialing or supervised experience, and the evidence that simulation improves patient outcomes is limited, as we discuss in our episode on simulation and patient outcomes.
Transcutaneous Pacing FAQ
Is a transcutaneous pacemaker the same as external pacing?
Yes. Transcutaneous pacing, transcutaneous pacemaker, transcutaneous pacer and external pacing all refer to pacing through skin pads, usually from a manual defibrillator.
Does transcutaneous pacing hurt?
Yes, in a conscious patient the muscle contractions can be extremely painful (StatPearls). Give analgesia, with light sedation as needed, without delaying pacing.
Is transcutaneous pacing the same as cardioversion?
No. Cardioversion is a shock synchronized to the QRS complex to treat a tachyarrhythmia (AHA, 2025), while TCP delivers repeated impulses to raise a slow rate, often from the same defibrillator.
What safety margin should you set for transcutaneous pacing?
It depends on the device. StatPearls suggests 5–10 mA above the capture threshold, while the ZOLL X Series Operator’s Guide describes a current about 10% above threshold. Follow your device’s operating instructions.
Can you use transcutaneous pacing in asystole?
Not routinely. The 2025 AHA guideline gives pacing during established adult cardiac arrest a Class 3: No Benefit recommendation, and the Cummins (1993) trial found no significant survival benefit.
Conclusion
Treat transcutaneous pacing as a temporary stabilization measure while treating the cause and arranging further pacing if needed. Pace when the patient is unstable and drugs have failed, or immediately in unstable high-degree AV block without IV or IO access, and prove capture twice: on the ECG and in the patient’s perfusion.
If you want a regular way to rehearse transvenous pacing, the Year 2 advanced procedures course covers transvenous pacing alongside central venous access, pericardiocentesis and cranial burr hole.
References
- Wigginton JG, Agarwal S, Bartos JA, et al. Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2025;152(16 suppl 2):S538-S577. doi:10.1161/CIR.0000000000001376. PubMed: https://pubmed.ncbi.nlm.nih.gov/41122884/
- Ivanov BS, Sheils E, Ahmed I. Transcutaneous pacing. In: StatPearls. StatPearls Publishing; updated February 23, 2026. https://www.ncbi.nlm.nih.gov/books/NBK519567/. PubMed: https://pubmed.ncbi.nlm.nih.gov/30137851/
- Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. Circulation. 2019;140:e382-e482. doi:10.1161/CIR.0000000000000628
- Smida T, Voges L, Crowe R, Scheidler J, Bardes J. Prehospital transcutaneous cardiac pacing in the United States: treatment epidemiology, predictors of treatment failure, and associated outcomes. Prehosp Emerg Care. 2025;29(5):578-585. doi:10.1080/10903127.2024.2393768. PubMed: https://pubmed.ncbi.nlm.nih.gov/39150824/
- Morrison LJ, Long J, Vermeulen M, et al. A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: ‘PrePACE’. Resuscitation. 2008;76(3):341-349. doi:10.1016/j.resuscitation.2007.08.008. PubMed: https://pubmed.ncbi.nlm.nih.gov/17933452/
- Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. N Engl J Med. 1993;328(19):1377-1382. doi:10.1056/NEJM199305133281903. PubMed: https://pubmed.ncbi.nlm.nih.gov/8474514/
- Moayedi S, Patel P, Brady N, Witting M, Dickfeld TL. Anteroposterior pacer pad position is better than anterolateral for transcutaneous cardiac pacing. Resuscitation. 2022;181:140-146. doi:10.1016/j.resuscitation.2022.11.009. PubMed: https://pubmed.ncbi.nlm.nih.gov/36410605/
- Goldschmied A, Sigle M, Toskas I, et al. Anteroposterior versus anterolateral pacer pad position in patients with symptomatic bradycardia. Int J Cardiol Heart Vasc. 2026;62:101857. doi:10.1016/j.ijcha.2025.101857. PubMed: https://pubmed.ncbi.nlm.nih.gov/42112511/
- Kimbrell J, Kreinbrook J, Poke D, et al. False electrical capture in prehospital transcutaneous pacing by paramedics: a case series. Prehosp Emerg Care. 2024;28(7):928-936. doi:10.1080/10903127.2024.2321287. PubMed: https://pubmed.ncbi.nlm.nih.gov/38407212/
- Smida T, Kimbrell JM, Kreinbrook JA, et al. The prevalence of sustained electrical capture during prehospital transcutaneous pacing: a multicenter observational study. Resuscitation. 2026;219:110934. doi:10.1016/j.resuscitation.2025.110934. PubMed: https://pubmed.ncbi.nlm.nih.gov/41443580/
- Holger JS, Lamon RP, Minnegan HJ, Gornick CC. Use of ultrasound to determine ventricular capture in transcutaneous pacing. Am J Emerg Med. 2003;21(3):227-229. doi:10.1016/s0735-6757(02)42252-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/12811719/
- Long B, Bridwell RE, DeVivo A, Gottlieb M. Transvenous pacemaker placement: a review for emergency clinicians. J Emerg Med. 2024;66(4):e492-e502. doi:10.1016/j.jemermed.2023.11.018. PubMed: https://pubmed.ncbi.nlm.nih.gov/38453595/
- Life in the Fast Lane (LITFL). Transcutaneous pacing. Accessed November 12, 2026. https://litfl.com/transcutaneous-pacing/ (expert teaching source)
- Physio-Control, Inc. LIFEPAK 15 Monitor/Defibrillator Operating Instructions. 2019. Accessed November 16, 2026. https://www.stryker.com/content/dam/stryker/ems/resources/operating-instructions/lifepak_15_operating_instructions_en.pdf (manufacturer instructions)
- ZOLL Medical Corporation. X Series Operator’s Guide. Accessed November 16, 2026. https://info.zoll.com/hubfs/Operator%27s%20Guide%20-%20X%20Series.pdf?hsLang=en-us (manufacturer instructions)